M&A & BD&L Outlook and Perspectives on Commercial Due Diligence

에 게시됨 5월 6, 20245/6/24

Please join our M&A, BD&L and Commercial Due Diligence (CDD) leaders to discuss our current perspectives on the state of deal-making in the pharmaceutical and biotech sectors, and to discuss our point of view on the heightened importance of Commercial Due Diligence in the current market and how to optimize CDD efforts using best practices and risk mitigation techniques.

Thu, May 23, 20224

2:00 – 3:00 PM EDT